The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell - Mediated cancer immunotherapy

Clinical Cancer Research

Volumn 13, Issue 8, 2007, Pages 2471-2478

  Palena, Claudia ^a   Polev, Dmitry E ^b   Tsang, Kwong Y ^a   Fernando, Romaine I ^a   Litzinger, Mary ^a   Krukovskaya, Larisa L ^b   Baranova, Ancha V ^b,c   Kozlov, Andrei P ^b   Schlom, Jeffrey ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Biomedical Center   (Russian Federation)

^c GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESODERMAL GROWTH FACTOR; PROTEIN BRACHYURY; T BOX TRANSCRIPTION FACTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CLUSTER ANALYSIS; COMPUTER AIDED DESIGN; COMPUTER MODEL; DATA BASE; EMBRYO DEVELOPMENT; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TUMOR GROWTH;

CARCINOMA; CELL LINE, TUMOR; DNA PRIMERS; DNA, COMPLEMENTARY; EPITHELIAL CELLS; EXPRESSED SEQUENCE TAGS; FETAL PROTEINS; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY; MESODERM; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; T-BOX DOMAIN PROTEINS;

EID: 34247887629     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2353     Document Type: Article

References (35)

1. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2: 442-54.
2. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15:740-6.
3. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005;17:548-58.
4. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-39.
5. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
6. Baranova AV, Lobashev AV, Ivanov DV, Krukovskaya LL, Yankovsky NK, Kozlov AP. In silico screening for tumour-specific expressed sequences in human genome. FEBS Lett 2001;508:143-8.
7. Krukovskaja LL, Baranova A, Tyezelova T, Polev D, Kozlov AP. Experimental study of human expressed sequences newly identified in silico as tumor specific. Tumor Biol 2005;26:17-24.
8. Edwards YH, Putt W, Lekoape KM, et al. The human homolog T of the mouse T (Brachyury) gene; gene structure, cDNA sequence, and assignment to chromosome 6q27. Genome Res 1996;6: 226-33.
9. Papaioannou VE, Silver LM. The T-box gene family. Bioessays 1998;20:9-19.
10. Kispert A, Herrmann BG, Leptin M, Reuter R. Homologs of the mouse Brachyury gene are involved in the specification of posterior terminal structures in Drosophila, Tribolium, and Locusta. Genes Dev 1994; 8:2137-50.
11. Herrmann BG, Labeit S, Poustka A, King TR, Lehrach H. Cloning of the T gene required in mesoderm formation in the mouse. Nature 1990;343:617-22.
12. Kispert A, Herrmann BG. Immunohistochemical analysis of the Brachyury protein in wild-type and mutant mouse embryos. Dev Biol 1994;161: 179-93.
13. Showell C, Binder O, Conlon FL. T-box genes in early embryogenesis. Dev Dyn 2004;229:201-18.
14. Technau U, Scholz CB. Origin and evolution of endoderm and mesoderm. Int J Dev Biol 2003;47: 531-9.
15. Behr R, Heneweer C, Viebahn C, Denker HW, Thie M. Epithelial-mesenchymal transition in colonies of rhesus monkey embryonic stem cells: a model for processes involved in gastrulation. Stem Cells 2005; 23:805-16.
16. Vidricaire G, Jardine K, McBurney MW. Expression of the Brachyury gene during mesoderm development in differentiating embryonal carcinoma cell cultures. Development 1994;120:115-22.
17. Shimojo N, Maloy WL, Anderson RW, Biddison WE, Coligan JE. Specificity of peptide binding by the HLA-A2.1 molecule. J Immunol 1989;143:2939-47.
18. Salter RD, Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 1986;5:943-9.
19. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994;152:163-75.
20. Tsang KY, Palena C, Yokokawa J, et al. Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin Cancer Res 2005;11:1597-607.
21. Palena C, Foon KA, Panicali D, et al. Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multi-ple costimulatory molecules. Blood 2005;106: 3515-23.
22. Scheurle D, De Young MP, Binninger DM, Page H, Jahanzeb M, Narayanan R. Cancer gene discovery using digital differential display. Cancer Res 2000;60: 4037-43.
23. Audic S, Claverie JM. The significance of digital gene expression profiles. Genome Res 1997;7:986-95.
24. Kispert A, Herrmann BG. The Brachyury gene encodes a novel DNA binding protein. EMBO J 1993;12: 3211-20.
25. Wilkinson DG, Bhatt S, Herrmann BG. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature 1990;343:657-9.
26. Smith JC, Price BM, Green JB, Weigel D, Herrmann BG. Expression of a Xenopus homolog of Brachyury (T) is an immediate-early response to mesoderm induction. Cell 1991;67:79-87.
27. Mahlamaki EH, Barlund M, Tanner M, et al. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 2002;35:353-8.
28. Sinclair CS, Adem C, Naderi A, et al. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res 2002;62:3587-91.
29. Fan W, Huang X, Chen C, Gray J, Huang T. TBX3 and its isoformTBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines. Cancer Res 2004; 64:5132-9.
30. Gokhale PJ, Giesberts AM, Andrews PW. Brachyury is expressed by human teratocarcinoma cells in the absence of mesodermal differentiation. Cell Growth Differ 2000;11:157-62.
31. Vujovic S, Henderson S, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 2006;209:157-65.
32. Romeo S, Hogendoorn PC. Brachyury and chordoma: the chondroid-chordoid dilemma resolved? J Pathol 2006;209:143-6.
33. Kang Y Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118:277-9.
34. Lu J, Celis E. Use of two predictive algorithms of the World Wide Web for the identification of tumor-reactive T-cell epitopes. Cancer Res 2000;60:5223-7.
35. Furlong MT, Hough CD, Sherman-Baust CA, Pizer ES, Morin PJ. Evidence for the colonic origin of ovarian cancer cell line SW626. J Natl Cancer Inst 1999;91:1327-8.